Skip to content

The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families

Exploring the Psychological Impact of the COVID-19 Outbreak on COVID-19 Survivors and Their Families

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04365348
Enrollment
300
Registered
2020-04-28
Start date
2020-05-27
Completion date
2023-06-30
Last updated
2021-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Wellness 1

Keywords

Stress, Anxiety, Depression, Families

Brief summary

Patients with COVID-19 diagnoses are treated under isolation in hospitals and with high-stress level. Currently, there is little information on the mental health implications of exposure amongst COVID-19 survivors and their family members. Research exploring the psychological impact amongst survivors of exposure to COVID-19 is desperately needed to understand the effects, mental health toll, and support required in survivors of COVID-19. This study aims to assess the psychological impact of the COVID-19 outbreak on COVID-19 survivors and their family members.

Detailed description

Since the 2019 coronavirus disease (COVID-19) was first reported, it has been rapidly transmitted and has aroused enormous global attention. Infected patients may develop severe and even fatal respiratory symptoms such as acute respiratory distress syndrome (ARDS) and acute respiratory failure, ending up in intensive care. Patients with COVID-19 diagnoses are treated under isolation in hospitals and with high-stress level. The stress and psychological impact on patients were also correlated significantly with several adverse psychological effects, such as fatigue, fear of social contact, poor sleep, loneliness, and depressed mood. The psychological impact of COVID-19 may also evolve and last for a prolonged period after discharge from the hospital. However, there is currently little information on the mental health implications of exposure amongst COVID-19 survivors and their family members. Research exploring the psychological impact amongst survivors of exposure to COVID-19 is desperately needed to understand the effects, mental health toll, and support required in survivors of COVID-19. This study aims to assess the psychological impact of the COVID-19 outbreak on COVID-19 survivors and their family members.

Interventions

None listed

Sponsors

Queen Mary Hospital, Hong Kong
CollaboratorOTHER
The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* COVID-19 survivors (i.e., diagnosed with COVID-19 and discharged from the hospital) and/or a family member of a COVID-19 survivor; * Aged 18 years or above; * No medical diagnosis of psychiatric illness

Exclusion criteria

• Refusal to give consent

Design outcomes

Primary

MeasureTime frameDescription
Stress level1 monthmeasured by the 10-item Perceived Stress Scale

Secondary

MeasureTime frameDescription
Social support1 month and 3 monthsmeasured by 6-item social support questionnaire
Stress level3 monthsmeasured by the 10-item Perceived Stress Scale
Negative emotion3 monthsmeasured by the 13-item Hospital Anxiety and Depression Scale
Quality of family functioning1 month and 3 monthsmeasured by 3-item Family Functioning Subscale
Severity of insomnia symptoms and the associated daytime impairment1 month and 3 monthsmeasured by the 7-item Insomnia Severity Index
Resilience1 month and 3 monthsmeasured by the 2-item Connor-Davidson Resilience Scale
Psychological effects1 month and 3 monthsmeasured by 10-item outcome-based questionnaire
Psychological response to trauma1 month and 3 monthsmeasured by the 22-item Impact of Event Scale -Revised

Countries

Hong Kong

Contacts

Primary ContactAgnes YK Lai, PhD
agneslai@hku.hk39176328
Backup ContactMary SM Ip, MD
msmip@hku.hk22554455

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026